Roche CEO Cautious on Alzheimer’s Trial Despite Eisai’s Success

Roche Holding AG’s chief executive officer cautioned that groundbreaking results for an Alzheimer’s disease treatment from a rival drugmaker don’t necessarily mean the Swiss company will be able to deliver similar success in its own upcoming clinical trial.